Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) was the target of a large increase in short interest in August. As of August 31st, there was short interest totalling 642,300 shares, an increase of 405.4% from the August 15th total of 127,100 shares. Currently, 4.0% of the company’s stock are short sold. Based on an average trading volume of 2,350,000 shares, the days-to-cover ratio is presently 0.3 days.
Cosmos Health Trading Down 6.7 %
NASDAQ:COSM traded down $0.07 on Thursday, hitting $1.00. The stock had a trading volume of 398,552 shares, compared to its average volume of 998,643. The company has a current ratio of 1.35, a quick ratio of 1.17 and a debt-to-equity ratio of 0.07. Cosmos Health has a 1 year low of $0.47 and a 1 year high of $2.05. The firm’s fifty day simple moving average is $1.17 and its two-hundred day simple moving average is $0.87.
Cosmos Health (NASDAQ:COSM – Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.10 EPS for the quarter. The firm had revenue of $15.84 million during the quarter. Cosmos Health had a negative net margin of 38.19% and a negative return on equity of 5.83%. Research analysts forecast that Cosmos Health will post -0.47 EPS for the current year.
Institutional Investors Weigh In On Cosmos Health
Cosmos Health Company Profile
Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.
Further Reading
- Five stocks we like better than Cosmos Health
- How to Capture the Benefits of Dividend Increases
- 3 Leveraged ETFs to Multiply Returns
- Most active stocks: Dollar volume vs share volume
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Health Care Stocks Explained: Why You Might Want to Invest
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.